A Landscape in Transition
The Cell Therapy 2026 Landscape Review offers a clear, data-driven view of a fast-evolving field at a pivotal moment. Drawing on Beacon Cell Therapy insights, the report explores how innovation, regulation, and commercial strategy are reshaping the global cell therapy ecosystem.
As the sector matures, established modalities such as CAR T remain central, while emerging approaches including in vivo cell therapies, next-generation targeting strategies, and advanced manufacturing platforms, are gaining traction. Activity is also expanding beyond oncology, signalling broader confidence in cell therapy across new disease areas.
This review captures a landscape in transition: investment is becoming more selective, clinical strategies more disciplined, and differentiation more critical than ever. Together, these insights highlight where momentum is building, where challenges remain, and what will define success in the next phase of cell therapy development.
Download your free copy today.
What’s Inside?
The Drug Landscape
Dive into the cell therapy drug landscape to explore why CAR NK cells and in vivo CAR therapies are gaining momentum, which cell types are rivaling T cells, the growing complexity of targeting strategies, and how CAR T continue therapeutic class dominance.
The Trial Landscape
The cell therapy trial landscape saw a revival in 2025, with initiations rising by 13.3% – but what are the key trends?
Overall, YoY growth has slowed, suggesting early signs of trial saturation. Many new trials remain early-stage, with the usual country suspects leading global trial activity.
Regulatory Announcements
Key regulatory updates from global authorities, highlighting new approvals, breakthrough designations, and expedited pathways that are shaping near-term commercial and clinical opportunities.
The Commercial Landscape
Deal activity in 2025 was dominated by early-stage financing and partnerships. This section reflects on the key deals – high-value deals and declining areas – and company shifts that shaped the cell therapy landscape last year.
The Future of Cell Therapy
Looking ahead, this section outlines where innovation is heading, including the expansion of key technologies and platforms, and what challenges developers, service providers, and CDMOs may face.
Previous Cell Therapy Landscape Reviews
Cell Therapy H1 2025 Landscape Review
Cell Therapy 2024 Landscape Review
Cell Therapy H1 2024 Landscape Review
You May Also Be Interested In…
Learn More About Cell Therapy
- The Most Comprehensive Way to Search the Cell Therapy Development Landscape: Unique search ontologies based on Cell Therapy drug and trial characteristics
- Market Leading Approach to Cell Therapy Preclinical & Clinical Data Curation: Manual curation of key Cell Therapy research and development data points by Cell Therapy research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Cell Therapy company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
